Medicare Enrolled
Dr. James Agresti, DO
Internal Medicine · Nutley, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Agresti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agresti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Agresti
Dr. James Agresti is an internal medicine specialist in Nutley, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Agresti performed 5,362 Medicare services across 1,917 unique beneficiaries.
Between the years covered by Open Payments, Dr. Agresti received a total of $7,505 from 66 pharmaceutical and/or device companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Agresti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NJ
$7,505 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,362
Medicare services
Top 5% in NJ for internal medicine
1,917
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~268 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
1,458 | $90 | $152 |
| Hymovis intra-articular injection An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space. |
912 | $13 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
838 | $47 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
538 | $48 | $300 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
289 | $24 | $177 |
| Annual depression screening | 261 | $21 | $40 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
232 | $55 | $275 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
187 | $10 | $90 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
158 | $12 | $50 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
92 | $152 | $259 |
| Prolonged nursing facility care, each 15 minutes This code covers additional time spent by a physician or qualified professional in a nursing facility beyond the standard duration of the primary evaluation and management service. |
83 | $27 | $45 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 59 | $20 | $45 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
59 | $34 | $40 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
57 | $57 | $142 |
| Dexamethasone intraocular injection, 1 microgram An injection of dexamethasone medication administered into the eye. The dose specified is 1 microgram. |
33 | $0 | $10 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
30 | $113 | $185 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
29 | $1 | $10 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
26 | $0 | $2 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
21 | $0 | $15 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
22.6% medium
76.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,505
Total received (2018-2024)
Avg $1,072/year across 7 years
Top 10% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
552
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,505 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,078
2023
$1,250
2022
$1,048
2021
$1,004
2020
$1,081
2019
$1,012
2018
$1,032
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$211
Azurity Pharmaceuticals, Inc.
$75
Amgen Inc.
$75
Bayer Healthcare Pharmaceuticals Inc.
$57
Lundbeck LLC
$57
Otsuka America Pharmaceutical, Inc.
$56
Exact Sciences Corporation
$54
Lilly USA, LLC
$52
Novartis Pharmaceuticals Corporation
$49
Almatica Pharma LLC
$48
Sumitomo Pharma America, Inc.
$44
Novo Nordisk Inc
$43
E.R. Squibb & Sons, L.L.C.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Xeris Pharmaceuticals, Inc.
$30
GlaxoSmithKline, LLC.
$28
PFIZER INC.
$28
ABBVIE INC.
$19
Ardelyx, Inc.
$15
Merck Sharp & Dohme LLC
$15
Phathom Pharmaceuticals, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$14
Mannkind Corporation
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
Top 3 companies account for 33.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$754
Novo Nordisk Inc
$714
Lilly USA, LLC
$568
Amgen Inc.
$461
Boehringer Ingelheim Pharmaceuticals, Inc.
$458
SANOFI-AVENTIS U.S. LLC
$360
PFIZER INC.
$352
Janssen Pharmaceuticals, Inc
$303
Sunovion Pharmaceuticals Inc.
$300
GlaxoSmithKline, LLC.
$206
Amarin Pharma Inc.
$189
Takeda Pharmaceuticals U.S.A., Inc.
$176
Novartis Pharmaceuticals Corporation
$170
ARBOR PHARMACEUTICALS, INC.
$153
Sumitomo Pharma America, Inc.
$146
Kowa Pharmaceuticals America, Inc.
$144
Otsuka America Pharmaceutical, Inc.
$137
Exact Sciences Corporation
$124
Almatica Pharma LLC
$116
Azurity Pharmaceuticals, Inc.
$104
E.R. Squibb & Sons, L.L.C.
$100
IDORSIA PHARMACEUTICALS US INC
$86
Eisai Inc.
$79
AbbVie Inc.
$77
Bayer Healthcare Pharmaceuticals Inc.
$71
Lundbeck LLC
$69
Avanir Pharmaceuticals, Inc.
$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$63
Noden Pharma USA Inc
$53
Bayer HealthCare Pharmaceuticals Inc.
$52
Scilex Pharmaceuticals Inc.
$48
Fidia Pharma USA Inc.
$45
Xeris Pharmaceuticals, Inc.
$43
Astellas Pharma US Inc
$42
Arbor Pharmaceuticals, Inc.
$41
Antares Pharma, Inc.
$41
Gilead Sciences, Inc.
$39
Allergan Inc.
$36
Althera Pharmaceuticals LLC
$35
Ardelyx, Inc.
$32
ABBVIE INC.
$31
Endo Pharmaceuticals Inc.
$28
IBSA Pharma Inc.
$26
Nabriva Therapeutics, plc
$26
UROVANT SCIENCES INC
$26
Mannkind Corporation
$26
Melinta Therapeutics, Inc.
$23
Merck Sharp & Dohme Corporation
$22
Avion Pharmaceuticals
$17
DePuy Synthes Sales Inc.
$16
Nestle HealthCare Nutrition Inc.
$15
Merck Sharp & Dohme LLC
$15
ACADIA Pharmaceuticals Inc
$14
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Phathom Pharmaceuticals, Inc.
$14
Paratek Pharmaceuticals, Inc.
$13
MannKind Corporation
$13
FIDIA PHARMA USA INC.
$13
Abbott Laboratories
$13
AbbVie, Inc.
$13
EISAI INC.
$12
IRONWOOD PHARMACEUTICALS, INC
$12
DEXCOM, INC.
$12
Alfasigma USA, Inc.
$12
Esperion Therapeutics, Inc.
$12
Acerus Pharmaceuticals Corporation
$12
Top 3 companies account for 27.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ABRYSVO · ADVAIR · AFREZZA · ANORO ELLIPTA · APTIOM · AREXVY · Aduhelm · Aimovig · BAQSIMI · BASAGLAR · BREO · BREZTRI · Baxdela · Belviq · CHANTIX · CREON · Cologuard Collection Kit · DALVANCE · DEXCOM G6 TRANSMITTER · DIFICID · Dayvigo · EDARBI · ELIQUIS · ENTRESTO · EVENITY · Edarbi · FARXIGA · FreeStyle Libre 2 · GEMTESA · GRALISE · GVOKE HYPOPEN · HORIZANT · HUMALOG · HYMOVIS · Horizant · Hymovis · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · KYNMOBI · Kerendia · LATUDA · LEQVIO · LINZESS · LIVALO · LOKELMA · LONHALA MAGNAIR · LOREEV XR · Licart · Linzess · Livalo · MOUNJARO · MYRBETRIQ · NASCOBAL · NEXLETOL · NP Thyroid 60 · NUEDEXTA · NUPLAZID · NURTEC ODT · NUZYRA · Natesto · ORTHOVISC · Otezla · Otrexup · Ozempic · PAXLOVID · PRALUENT · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QUVIVIQ · REXULTI · Repatha · Roszet · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Seglentis · Synthroid · TEKTURNA · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Trintellix · UBRELVY · UTIBRON NEOHALER · Uloric · Utibron · VESICARE · VOQUEZNA · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xenleta · ZENPEP · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
10,476
Per 100K population
1226.5
County median income
$76,712
Nearest hospital
CLARA MAASS MEDICAL CENTER
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Agresti is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NJ), with low-engagement industry engagement in the top 10% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Agresti experienced with nursing facility visit, moderate complexity?
Based on Medicare claims data, Dr. Agresti performed 1,458 nursing facility visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Agresti receive payments from pharmaceutical companies?
Yes. Dr. Agresti received a total of $7,505 from 66 companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agresti's costs compare to other internal medicine physicians in Nutley?
Dr. Agresti's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agresti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Nutley
Browse internal medicine physicians in Nutley ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology